Forecast for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional
This grant funds the development of non-addictive analgesic therapeutics to treat pain.
About this program
The HEAL Initiative aims to accelerate the development of non-addictive pain management therapies. This grant focuses on the research and development of small molecules and biologics that can effectively alleviate pain without the risk of addiction. It is intended for researchers and organizations engaged in innovative therapeutic development in the healthcare sector. The initiative encourages collaboration among various stakeholders to bring new solutions to market that can address the ongoing opioid crisis and improve patient outcomes.
Eligibility
Eligible applicants include academic institutions, nonprofit organizations, and for-profit entities engaged in healthcare research and development.
Requirements
- Must focus on non-addictive analgesic therapeutics
- Clinical trial optional